News

Current News in Drug Discovery

Nature Reviews Drug Discovery

From gene hunter to drug hunter August 14, 2025
Nature Reviews Drug Discovery, Published online: 14 August 2025; doi:10.1038/d41573-025-00139-2Howard Chang, Amgen’s new CSO, discusses genetic target discovery, extrachromosomal DNA and technology development.
Asher Mullard
Neutrophil-targeted drug secures first FDA approval for inflammatory lung disease August 12, 2025
Nature Reviews Drug Discovery, Published online: 12 August 2025; doi:10.1038/d41573-025-00135-6Neutrophil-targeted drug secures first FDA approval for inflammatory lung disease
Katie Kingwell
Leading orexin receptor agonist clears phase III for narcolepsy August 7, 2025
Nature Reviews Drug Discovery, Published online: 07 August 2025; doi:10.1038/d41573-025-00137-4Leading orexin receptor agonist clears phase III for narcolepsy
Asher Mullard
Small-molecule PI3Kα binder with selective anticancer activity August 7, 2025
Nature Reviews Drug Discovery, Published online: 07 August 2025; doi:10.1038/d41573-025-00136-5Small-molecule PI3Kα binder with selective anticancer activity
Katie Kingwell
FDA grants first US approval for decades-old eye drug August 7, 2025
Nature Reviews Drug Discovery, Published online: 07 August 2025; doi:10.1038/d41573-025-00138-3FDA grants first US approval for decades-old eye drug
Asher Mullard
In vivo engineering broadens CAR-T cell therapy use August 5, 2025
Nature Reviews Drug Discovery, Published online: 05 August 2025; doi:10.1038/d41573-025-00134-7In vivo engineering broadens CAR-T cell therapy use
M. Teresa Villanueva
How multispecific molecules are transforming pharmacotherapy August 1, 2025
Nature Reviews Drug Discovery, Published online: 01 August 2025; doi:10.1038/s41573-025-01262-wMultispecific drugs are designed to engage two or more entities to exert their pharmacological effect. This Perspective discusses how a new wave of FDA-approved multispecific molecules have been transformative in overcoming barriers to drug development such as toxicity, rapid clearance, undruggable protein features, and functional redundancy.
Raymond J. Deshaies
Broader horizons for cereblon glue degraders July 31, 2025
Nature Reviews Drug Discovery, Published online: 31 July 2025; doi:10.1038/d41573-025-00133-8Broader horizons for cereblon glue degraders
Alex Eccleston

Vitreon America™ Launches Botanicopeia™ Database and Federal Government Services at NIH Festival+

BETHESDA, MD, September 17, 2016 − Vitreon America, Inc.^™ participated this week in the National Institute of Health (NIH) Intramural Research Program’s 30^th Annual NIH Research Festival which was held September 15-16, 2016 at the NIH Bethesda, Maryland campus.

The Festival included plenary sessions, symposia, exhibits, poster sessions and tours designed to encourage sharing and learning about the exciting research taking place on NIH campus.

Vitreon America^™ was selected by the Technical Sales Association (TSA) which sponsors the Research Festival Exhibit, to launch its state-of-the-art Phytochemical and Ethnobotanical database subscription services, Botanicopeia^™.

Attending on behalf of Vitreon America^™
were Michael Megginson, VP of Business Development (left) and Jorgen Sandberg,
CEO (right).

Vitreon America was pleased to see the interest from the NIH Institutions to utilize the Botanicopeia^™ database subscriptions with many NIH researchers expressing interest in considering the Vitreon America Botanical Research Analytic services as well to optimize the Botanicopeia^™ database.

Based on the NIH researchers feedback, Vitreon America has established a Botanicopeia^™ database subscription service agreement and subscription service with botanical research analytic services through Marshall Communications Corporation, www.marshallcomm.com.

Vitreon America services are available through Marshall Communications Corporation (VOSB) on NIH’s Information Technology Acquisition and Assessment Center’s (NITAAC)- Government-wide Acquisition Contract (GWAC) vehicle. [Prime Contract Holder #HHSN316201500063W]

Vitreon America^™ was established with the goal of commercializing their Botanicopeia^™ database and botanical research analytic services for development of botanicals and phytochemicals in the creation of new medicinal products by Vitreon America Clients.

To find out more about our Services please contact us for assistance at 1-888-214-2584 or at info@vitreonamerica.com

About Vitreon America™

Vitreon America^TM was formed with the goal of disseminating their Botanicopeia^TM database to encourage the increased use of botanicals and phytochemicals in the creation of new medicines.

Contact Vitreon America, Inc.

Vitreon America Botanical Research Center @ Hopkins Johns Hopkins University

MCC 9601 Medical Center Drive, Suite 221
Rockville, Maryland 20850

+1-888-214-2584

j.shaver@advasur.com